COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.
Innovative Phase 1 Trial to Protect the Brains of Infants with Critical Congenital Heart Disease During and After Surgery (MEDCAP)
A phase 1 trial at Children's National Hospital studies the use of mesenchymal stromal cells (MSCs) as a potential protection for the brains of infants undergoing cardiac surgery. This is the first study to infuse these MSCs via the cardiopulmonary bypass, or heart-lung machine.
About the Expert
Mary Donofrio, MD, FAAP, FACC
Medical Director, Prenatal Cardiology Program
Co-Director, Cardiac Neurodevelopmental Outcome Program
Advanced Imaging Cardiologist
Catherine Bollard, M.D., M.B.Ch.B.
Director, Center for Cancer & Immunology Research
Bosworth Chair for Cancer Biology
Director, Program for Cell Enhancement and Technologies for Immunotherapy (CETI)
Attending Physician, Division of Bone and Marrow Transplantation
Richard Jonas, M.D.
Emeritus Chief, Division of Cardiac Surgery
Senior Investigator, Center for Neuroscience Research
Nobuyuki Ishibashi, M.D.
Foglia-Hills Professor of Pediatric Cardiac Research
Director of Cardiac Surgery Research Laboratory
Make an Appointment
Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.
Make it happen